TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 314 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46,196 | -6.8% | 3,570 | 0.0% | 0.00% | – |
| Q1 2024 | $49,587 | -39.6% | 3,570 | -37.9% | 0.00% | – |
| Q4 2023 | $82,052 | +137.3% | 5,750 | +157.3% | 0.00% | – |
| Q3 2023 | $34,575 | -1.5% | 2,235 | 0.0% | 0.00% | – |
| Q2 2023 | $35,112 | -4.7% | 2,235 | 0.0% | 0.00% | – |
| Q1 2023 | $36,833 | +6.7% | 2,235 | +1.0% | 0.00% | – |
| Q4 2022 | $34,523 | -47.8% | 2,213 | -56.7% | 0.00% | – |
| Q3 2022 | $66,164 | +53.9% | 5,114 | +115.3% | 0.00% | – |
| Q4 2020 | $43,000 | +13.2% | 2,375 | +12.5% | 0.00% | – |
| Q3 2020 | $38,000 | – | 2,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |